Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 17/20 | 0.42 |
| ▸ | MMP13 | P45452 | 14/20 | 0.42 |
| ▸ | MMP2 | P08253 | 7/20 | 0.42 |
| ▸ | MMP3 | P08254 | 7/20 | 0.42 |
| ▸ | MMP9 | P14780 | 7/20 | 0.42 |
| ▸ | MMP8 | P22894 | 6/20 | 0.42 |
| ▸ | MMP14 | P50281 | 6/20 | 0.42 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25364 | 0.80 | MMP1 (0.52) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7208148 | 0.70 | MMP1 (0.52) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7209180 | 0.69 | MMP1 (0.57) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7213095 | 0.69 | MMP1 (0.49) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7208607 | 0.69 | MMP1 (0.52) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7209154 | 0.68 | MMP1 (0.47) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7209196 | 0.68 | MMP1 (0.53) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7212961 | 0.66 | MMP1 (0.48) | MMP1MMP13MMP2MMP3MMP9 | |
| Hydroxyamine SCHEMBL5914587 | 0.66 | MMP1 (0.76) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL2575324 | 0.65 | MMP1 (0.79) | MMP1MMP13MMP2MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700742-B2 | gene therapy; immunoglobulins; hybridomas; monoclonal antibodies | AMGEN FREMONT (US) | 2010-04-20 | — | — | US | disclosed |